应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
SMMT Summit Therapeutics PLC
盘前交易 07-03 07:31:13 EDT
7.54
-0.60
-7.37%
最高
8.19
最低
7.53
成交量
266.90万
今开
8.14
昨收
8.14
日振幅
8.11%
总市值
52.93亿
流通市值
5.53亿
总股本
7.02亿
成交额
2,069万
换手率
3.64%
流通股本
7,333万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.19%报8.42美元
自选股智能写手 · 06-25
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.19%报8.42美元
Summit Therapeutics Inc.盘中异动 急速上涨5.04%
自选股智能写手 · 06-24
Summit Therapeutics Inc.盘中异动 急速上涨5.04%
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.48%报7.93美元
自选股智能写手 · 06-17
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.48%报7.93美元
Summit Therapeutics Inc.盘中异动 早盘急速拉升5.17%
自选股智能写手 · 06-12
Summit Therapeutics Inc.盘中异动 早盘急速拉升5.17%
Summit Therapeutics Inc.盘中异动 大幅下挫5.14%
自选股智能写手 · 06-11
Summit Therapeutics Inc.盘中异动 大幅下挫5.14%
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.00%
自选股智能写手 · 06-05
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.00%
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.09%
自选股智能写手 · 06-04
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.09%
Summit Therapeutics Inc.股价上涨10.59% 市值涨7.14亿美元
自选股智能写手 · 06-03
Summit Therapeutics Inc.股价上涨10.59% 市值涨7.14亿美元
Summit Therapeutics - 收到并接受来自机构投资者的自愿要约以每股9.00美元的价格购买公司的22.2万股普通股。
智通财经 · 06-03
Summit Therapeutics - 收到并接受来自机构投资者的自愿要约以每股9.00美元的价格购买公司的22.2万股普通股。
BUZZ-由于 Summit Therapeutics 疗法在研究中取得成功，中国的 Akeso 公司创下近三年来的最高点
Reuters · 05-31
BUZZ-由于 Summit Therapeutics 疗法在研究中取得成功，中国的 Akeso 公司创下近三年来的最高点
肺癌疗法试验结果实现主要终点 Summit Therapeutics(SMMT.US)暴涨逾270%
智通财经 · 05-31
肺癌疗法试验结果实现主要终点 Summit Therapeutics(SMMT.US)暴涨逾270%
成分股Summit Therapeutics Plc.收涨272.06%领跑使得最近六个月累计涨幅达到412.68%其竞争对手默克制药则收跌1.09%；北京时间02:32（距离美股收盘不到90分钟）该公司宣布Harmoni-2第三阶段临床试验结果实现主要终点其控制特定类型肺癌的效果超越默克制药的Keytruda。Humacyte涨18.03%Xeris Pharmaceuticals涨15.03%AC Immune涨8.17%Sarepta...
智通财经 · 05-31
成分股Summit Therapeutics Plc.收涨272.06%领跑使得最近六个月累计涨幅达到412.68%其竞争对手默克制药则收跌1.09%；北京时间02:32（距离美股收盘不到90分钟）该公司宣布Harmoni-2第三阶段临床试验结果实现主要终点其控制特定类型肺癌的效果超越默克制药的Keytruda。Humacyte涨18.03%Xeris Pharmaceuticals涨15.03%AC Immune涨8.17%Sarepta...
Summit Therapeutics 癌症疗法在中国后期研究中获得成功
Reuters · 05-31
Summit Therapeutics 癌症疗法在中国后期研究中获得成功
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.28%报2.78美元
自选股智能写手 · 05-30
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.28%报2.78美元
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.02%报2.51美元
自选股智能写手 · 05-29
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.02%报2.51美元
Summit Therapeutics Inc.盘中异动 股价大跌5.03%
自选股智能写手 · 05-28
Summit Therapeutics Inc.盘中异动 股价大跌5.03%
Summit Therapeutics Inc.盘中异动 早盘大幅下跌16.90%
自选股智能写手 · 05-24
Summit Therapeutics Inc.盘中异动 早盘大幅下跌16.90%
Summit Therapeutics Inc.盘中异动 急速下挫5.46%
自选股智能写手 · 05-09
Summit Therapeutics Inc.盘中异动 急速下挫5.46%
加载更多
公司概况
公司名称：
Summit Therapeutics PLC
所属市场：
NASDAQ
上市日期：
--
主营业务：
Summit Therapeutics Inc.于2013年11月22日在英格兰和威尔士注册成立，特拉华州的一家公司（“New Summit”）已成为该公司的后续发行方。该公司是一家生物制药公司，专注于发现、开发和商业化对患者、医生、护理人员和社会友好的药物疗法，旨在提高生活质量，延长潜在寿命，并解决严重的未满足的医疗需求。该公司的候选产品管线的设计目标是成为肿瘤治疗领域中对患者友好的、新时代的标准护理药物。
发行价格：
--
{"stockData":{"symbol":"SMMT","market":"US","secType":"STK","nameCN":"Summit Therapeutics PLC","latestPrice":7.54,"timestamp":1719950400000,"preClose":8.14,"halted":0,"volume":2668976,"delay":0,"floatShares":73332900,"shares":701979596,"eps":-0.165619,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.6,"latestTime":"07-03 07:31:13 EDT","open":8.14,"high":8.19,"low":7.53,"amount":20691702.4432096,"amplitude":0.081081,"askPrice":7.68,"askSize":100,"bidPrice":7.55,"bidSize":127,"shortable":3,"etf":0,"ttmEps":-0.165619,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1720013400000},"adr":1,"listingDate":1425531600000,"adjPreClose":7.54,"adrRate":5,"postHourTrading":{"tag":"盘后","latestPrice":7.6,"preClose":7.54,"latestTime":"19:57 EDT","volume":18907,"amount":144586.2934,"timestamp":1719964671793},"volumeRatio":1.0303253455538628,"impliedVol":0.7521,"impliedVolPercentile":0.2351},"requestUrl":"/m/hq/s/SMMT","defaultTab":"news","newsList":[{"id":"2446537847","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.19%报8.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446537847","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446537847?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:21","pubTimestamp":1719325312,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日22时21分，Summit Therapeutics Inc.股票出现异动，股价快速拉升5.19%。截至发稿，该股报8.42美元/股，成交量41.1817万股，换手率0.06%，振幅5.88%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062522215296816a71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062522215296816a71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT","BK4139"],"gpt_icon":0},{"id":"2445077597","title":"Summit Therapeutics Inc.盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445077597","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445077597?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:58","pubTimestamp":1719237510,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时58分，Summit Therapeutics Inc.股票出现波动，股价快速上涨5.04%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Revelation Biosciences, Inc.、Geovax Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1325.97%、92.30%、58.57%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Geovax Labs Inc C/Wts 29/09/2025、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为138.91%、51.43%、50.87%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624215830af8eec7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624215830af8eec7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2444160687","title":"Summit Therapeutics Inc.盘中异动 早盘股价大跌5.48%报7.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444160687","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444160687?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:47","pubTimestamp":1718632035,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时47分，Summit Therapeutics Inc.股票出现异动，股价快速下挫5.48%。截至发稿，该股报7.93美元/股，成交量63.0533万股，换手率0.09%，振幅8.94%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214716af8de362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214716af8de362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2442554413","title":"Summit Therapeutics Inc.盘中异动 早盘急速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442554413","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442554413?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199096,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Summit Therapeutics Inc.股票出现异动，股价大幅拉升5.17%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为36.71%、18.94%、3.60%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc，振幅分别为21.10%、20.93%、8.28%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213136941ee0a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213136941ee0a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT","BK4139"],"gpt_icon":0},{"id":"2442316728","title":"Summit Therapeutics Inc.盘中异动 大幅下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442316728","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442316728?lang=zh_cn&edition=full","pubTime":"2024-06-11 23:50","pubTimestamp":1718121002,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日23时50分，Summit Therapeutics Inc.股票出现异动，股价大幅下跌5.14%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611235002aef45e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611235002aef45e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SMMT"],"gpt_icon":0},{"id":"2441279425","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441279425","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441279425?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:38","pubTimestamp":1717594714,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时38分，Summit Therapeutics Inc.股票出现波动，股价大幅拉升5.00%。截至发稿，该股报7.67美元/股，成交量32.3万股，换手率0.05%，振幅5.82%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605213834968122ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605213834968122ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SMMT"],"gpt_icon":0},{"id":"2440235813","title":"Summit Therapeutics Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440235813","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440235813?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:30","pubTimestamp":1717507849,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时30分，Summit Therapeutics Inc.股票出现波动，股价大幅下挫5.09%。截至发稿，该股报8.39美元/股，成交量21.2653万股，换手率0.03%，振幅1.47%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060421304996811ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060421304996811ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT","BK4139"],"gpt_icon":0},{"id":"2440251493","title":"Summit Therapeutics Inc.股价上涨10.59% 市值涨7.14亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440251493","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440251493?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:31","pubTimestamp":1717421463,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时31分，Summit Therapeutics Inc.股票出现波动，股价急速上涨10.59%。截至发稿，该股报9.61美元/股，成交量429.835万股，换手率0.61%，振幅3.86%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032131049f156afc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032131049f156afc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SMMT"],"gpt_icon":0},{"id":"2440450082","title":"Summit Therapeutics - 收到并接受来自机构投资者的自愿要约以每股9.00美元的价格购买公司的22.2万股普通股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440450082","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440450082?lang=zh_cn&edition=full","pubTime":"2024-06-03 17:45","pubTimestamp":1717407925,"startTime":"0","endTime":"0","summary":"Summit Therapeutics - 收到并接受来自机构投资者的自愿要约以每股9.00美元的价格购买公司的22.2万股普通股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406031745289f14d32d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406031745289f14d32d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2439693341","title":"BUZZ-由于 Summit Therapeutics 疗法在研究中取得成功，中国的 Akeso 公司创下近三年来的最高点","url":"https://stock-news.laohu8.com/highlight/detail?id=2439693341","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439693341?lang=zh_cn&edition=full","pubTime":"2024-05-31 10:38","pubTimestamp":1717123132,"startTime":"0","endTime":"0","summary":"** Summit Therapeutics 表示， ，其治疗一种肺癌患者的实验疗法达到了一项后期研究的主要目标，该研究由Akeso赞助，在中国进行。** Summit 称，在头对头研究中，其疗法与默克公司的 Keytruda相比在统计学上有显著改善。** Akeso股价年累计下跌8.5","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","SMMT","BK1161","LU1720050803.USD","BK4139","BK1574","LU0348784397.USD","LU1794554557.SGD","LU0417516571.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0348783233.USD"],"gpt_icon":0},{"id":"2439984822","title":"肺癌疗法试验结果实现主要终点 Summit Therapeutics(SMMT.US)暴涨逾270%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439984822","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439984822?lang=zh_cn&edition=full","pubTime":"2024-05-31 09:16","pubTimestamp":1717118204,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物制药公司Summit Therapeutics周四收盘大涨逾272.06%，此前该公司表示，其主要资产ivonescimab成为首个在非小细胞肺癌后期试验中表现优于默沙东抗PD-1免疫疗法Keytruda的药物。受此影响，默沙东股价下挫，周四收跌1.09%。Summit援引其在中国进行的HARMONi-2 3期试验的中期数据称，ivonescimab是一种阻断致癌PD-1受体的双特异性抗体，作为一线治疗达到了其无进展生存期的主要终点。Summit表示，PFS优势在不同的患者群体中都有体现，包括PD-L1表达低或高以及鳞状或非鳞状组织的患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1128799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09926","SMMT","BK1161","LU1720050803.USD","BK4139","BK1574","LU0348784397.USD","LENZ","LU1794554557.SGD","LU0417516571.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0348783233.USD"],"gpt_icon":0},{"id":"2439012656","title":"成分股Summit Therapeutics Plc.收涨272.06%领跑使得最近六个月累计涨幅达到412.68%其竞争对手默克制药则收跌1.09%；北京时间02:32（距离美股收盘不到90分钟）该公司宣布Harmoni-2第三阶段临床试验结果实现主要终点其控制特定类型肺癌的效果超越默克制药的Keytruda。Humacyte涨18.03%Xeris Pharmaceuticals涨15.03%AC Immune涨8.17%Sarepta...","url":"https://stock-news.laohu8.com/highlight/detail?id=2439012656","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439012656?lang=zh_cn&edition=full","pubTime":"2024-05-31 06:06","pubTimestamp":1717106796,"startTime":"0","endTime":"0","summary":"成分股Summit Therapeutics Plc.收涨272.06%领跑使得最近六个月累计涨幅达到412.68%其竞争对手默克制药则收跌1.09%；北京时间02:32该公司宣布Harmoni-2第三阶段临床试验结果实现主要终点其控制特定类型肺癌的效果超越默克制药的Keytruda。Humacyte涨18.03%Xeris Pharmaceuticals涨15.03%AC Immune涨8.17%Sarepta Therapeutics也涨7.05%；Structure Therapeutics ADR则收跌6.79%表现倒数第三23Andme Holding Co.跌8.34%Immunovant也跌10.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310606379f075b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310606379f075b2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","LU0238689110.USD","LU0965509010.AUD","IE00BJT1NW94.SGD","BK4585","LU2023250843.SGD","LU1057294990.SGD","IE00B2B36J28.USD","BK4588","LU0234572021.USD","LU0965509101.SGD","LU1430594728.SGD","LU0070302665.USD","SG9999014542.SGD","LU0266013472.USD","LU0122379950.USD","LU0208291251.USD","LU0965509283.SGD","IE00BLSP4452.SGD","SG9999013999.USD","LU1989772840.SGD","LU2468319806.SGD","SG9999002232.USD","MRK","LU1585245621.USD","LU1093756168.USD","SG9999001440.SGD","LENZ","SMMT","LU1023059063.AUD","BK4135","IE00BBT3K403.USD","LU2023250504.SGD","SG9999002224.SGD","IE00BSNM7G36.USD","LU0058720904.USD","LU2106854487.HKD","IE00BFTCPJ56.SGD","SG9999001176.USD","IE00B1BXHZ80.USD","LU0289739699.SGD","IE00BLSP4239.USD","LU0320765489.SGD","LU0985320562.USD","LU1974910355.USD","LU1291159041.SGD","LU0861579265.USD","AC","BK4139","LU1989771016.USD"],"gpt_icon":0},{"id":"2439674263","title":"Summit Therapeutics 癌症疗法在中国后期研究中获得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2439674263","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439674263?lang=zh_cn&edition=full","pubTime":"2024-05-31 03:30","pubTimestamp":1717097419,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) 路透5月30日 - Summit Therapeutics 周四表示，该公司用于治疗一种肺癌患者的实验性疗法达到了在中国进行的一项晚期研究的主要目标。该公司称，与默克公司 的Keytruda相比，其疗法在头对头研究中显示出了统计学上的显著改善。该公司股价上涨了一倍多，达到7.48美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","LU2468319806.SGD","LU1989771016.USD","LU1023059063.AUD","LU1093756168.USD","LU0965509283.SGD","LU1093756325.SGD","SMMT","SG9999013999.USD","IE00BLSP4239.USD","BK4588","LU0965509010.AUD","BK4139","SG9999001176.SGD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU0965509101.SGD","LU0238689110.USD","BK4559","LU0122379950.USD","LU2023250843.SGD","MRK","LU2106854487.HKD","IE00B1BXHZ80.USD","LU2361045086.USD","LU2361044865.SGD","LU2461242641.AUD","BK4007","LU2361044949.HKD","LU0208291251.USD","LU0289739699.SGD","BK4534","LU1291159041.SGD","LU0058720904.USD","IE00BSNM7G36.USD","BK4516","LU1066051498.USD","IE00BLSP4452.SGD","LU1057294990.SGD","SG9999001440.SGD","LU0266013472.USD","BK4533","SG9999001176.USD","LU0211331839.USD","IE00BJT1NW94.SGD","SG9999014542.SGD","LU1989772840.SGD","LU1585245621.USD","IE0002141913.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2439642622","title":"Summit Therapeutics Inc.盘中异动 早盘股价大跌5.28%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439642622","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439642622?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:31","pubTimestamp":1717075892,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时31分，Summit Therapeutics Inc.股票出现异动，股价急速下挫5.28%。截至发稿，该股报2.78美元/股，成交量12.2753万股，换手率0.02%，振幅2.21%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213132941eb325&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213132941eb325&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SMMT"],"gpt_icon":0},{"id":"2439573106","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.02%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439573106","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439573106?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:22","pubTimestamp":1716992553,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时22分，Summit Therapeutics Inc.股票出现异动，股价急速上涨5.02%。截至发稿，该股报2.51美元/股，成交量106.712万股，换手率0.15%，振幅8.15%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.14%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405292222349681087f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405292222349681087f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SMMT"],"gpt_icon":0},{"id":"2438377851","title":"Summit Therapeutics Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438377851","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438377851?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:32","pubTimestamp":1716903127,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时32分，Summit Therapeutics Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报3.21美元/股，成交量20.5464万股，换手率0.03%，振幅4.73%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.86%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213207968103bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213207968103bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SMMT"],"gpt_icon":0},{"id":"2437602037","title":"Summit Therapeutics Inc.盘中异动 早盘大幅下跌16.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437602037","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437602037?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:31","pubTimestamp":1716557486,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时31分，Summit Therapeutics Inc.股票出现波动，股价快速跳水16.90%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。消息层面，截至21时31分，《斯迪富维持Summit Therapeutics买入评级，维持目标价8美元》资讯为影响Summit Therapeutics Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213126955940c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213126955940c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT","BK4139"],"gpt_icon":0},{"id":"2434045779","title":"Summit Therapeutics Inc.盘中异动 急速下挫5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434045779","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434045779?lang=zh_cn&edition=full","pubTime":"2024-05-09 01:10","pubTimestamp":1715188207,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日01时10分，Summit Therapeutics Inc.股票出现异动，股价快速跳水5.46%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。该信息摘要如下：Summit Therapeutics获花旗首次覆盖，给予买入评级, 目标价7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090110087a58c757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090110087a58c757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.smmttx.com","stockEarnings":[{"period":"1week","weight":-0.0587},{"period":"1month","weight":-0.1318},{"period":"3month","weight":0.9089},{"period":"6month","weight":1.803},{"period":"1year","weight":2.1157},{"period":"ytd","weight":1.8889}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Summit Therapeutics Inc.于2013年11月22日在英格兰和威尔士注册成立，特拉华州的一家公司（“New Summit”）已成为该公司的后续发行方。该公司是一家生物制药公司，专注于发现、开发和商业化对患者、医生、护理人员和社会友好的药物疗法，旨在提高生活质量，延长潜在寿命，并解决严重的未满足的医疗需求。该公司的候选产品管线的设计目标是成为肿瘤治疗领域中对患者友好的、新时代的标准护理药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.110315},{"month":2,"riseRate":0.444444,"avgChangeRate":0.031629},{"month":3,"riseRate":0.444444,"avgChangeRate":0.039733},{"month":4,"riseRate":0.4,"avgChangeRate":0.012892},{"month":5,"riseRate":0.6,"avgChangeRate":0.133904},{"month":6,"riseRate":0.3,"avgChangeRate":-0.112221},{"month":7,"riseRate":0.5,"avgChangeRate":0.031507},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.019737},{"month":9,"riseRate":0.333333,"avgChangeRate":0.030056},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.032299},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.012593},{"month":12,"riseRate":0.555556,"avgChangeRate":0.442254}],"exchange":"NASDAQ","name":"Summit Therapeutics PLC","nameEN":"Summit Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Summit Therapeutics PLC,SMMT,Summit Therapeutics PLC股票,Summit Therapeutics PLC股票老虎,Summit Therapeutics PLC股票老虎国际,Summit Therapeutics PLC行情,Summit Therapeutics PLC股票行情,Summit Therapeutics PLC股价,Summit Therapeutics PLC股市,Summit Therapeutics PLC股票价格,Summit Therapeutics PLC股票交易,Summit Therapeutics PLC股票购买,Summit Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}